These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24451919)

  • 1. Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism.
    Chantiluke K; Barrett N; Giampietro V; Brammer M; Simmons A; Murphy DG; Rubia K
    Cereb Cortex; 2015 Jul; 25(7):1757-70. PubMed ID: 24451919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorder-dissociated effects of fluoxetine on brain function of working memory in attention deficit hyperactivity disorder and autism spectrum disorder.
    Chantiluke K; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2015 Apr; 45(6):1195-205. PubMed ID: 25292351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse fluoxetine effects on inhibitory brain activation in non-comorbid boys with ADHD and with ASD.
    Chantiluke K; Barrett N; Giampietro V; Santosh P; Brammer M; Simmons A; Murphy DG; Rubia K
    Psychopharmacology (Berl); 2015 Jun; 232(12):2071-82. PubMed ID: 25533997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acute fluoxetine administration on temporal discounting in youth with ADHD.
    Carlisi CO; Chantiluke K; Norman L; Christakou A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2016 Apr; 46(6):1197-209. PubMed ID: 26708124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorder-specific functional abnormalities during temporal discounting in youth with Attention Deficit Hyperactivity Disorder (ADHD), Autism and comorbid ADHD and Autism.
    Chantiluke K; Christakou A; Murphy CM; Giampietro V; Daly EM; Ecker C; Brammer M; Murphy DG; ; Rubia K
    Psychiatry Res; 2014 Aug; 223(2):113-20. PubMed ID: 24929553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating neural reward responsiveness in autism versus ADHD.
    Kohls G; Thönessen H; Bartley GK; Grossheinrich N; Fink GR; Herpertz-Dahlmann B; Konrad K
    Dev Cogn Neurosci; 2014 Oct; 10():104-16. PubMed ID: 25190643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorder-specific functional abnormalities during sustained attention in youth with Attention Deficit Hyperactivity Disorder (ADHD) and with autism.
    Christakou A; Murphy CM; Chantiluke K; Cubillo AI; Smith AB; Giampietro V; Daly E; Ecker C; Robertson D; ; Murphy DG; Rubia K
    Mol Psychiatry; 2013 Feb; 18(2):236-44. PubMed ID: 22290121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorder-specific dysfunction in right inferior prefrontal cortex during two inhibition tasks in boys with attention-deficit hyperactivity disorder compared to boys with obsessive-compulsive disorder.
    Rubia K; Cubillo A; Smith AB; Woolley J; Heyman I; Brammer MJ
    Hum Brain Mapp; 2010 Feb; 31(2):287-99. PubMed ID: 19777552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
    Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative meta-analyses of brain structural and functional abnormalities during cognitive control in attention-deficit/hyperactivity disorder and autism spectrum disorder.
    Lukito S; Norman L; Carlisi C; Radua J; Hart H; Simonoff E; Rubia K
    Psychol Med; 2020 Apr; 50(6):894-919. PubMed ID: 32216846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention.
    Rubia K; Smith AB; Halari R; Matsukura F; Mohammad M; Taylor E; Brammer MJ
    Am J Psychiatry; 2009 Jan; 166(1):83-94. PubMed ID: 18829871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorder-specific inferior prefrontal hypofunction in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure conduct disorder during cognitive flexibility.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Scott S; Brammer M
    Hum Brain Mapp; 2010 Dec; 31(12):1823-33. PubMed ID: 20205245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation.
    Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ
    J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired reward processing in the human prefrontal cortex distinguishes between persistent and remittent attention deficit hyperactivity disorder.
    Wetterling F; McCarthy H; Tozzi L; Skokauskas N; O'Doherty JP; Mulligan A; Meaney J; Fagan AJ; Gill M; Frodl T
    Hum Brain Mapp; 2015 Nov; 36(11):4648-63. PubMed ID: 26287509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder.
    Rubia K; Halari R; Cubillo A; Smith AB; Mohammad AM; Brammer M; Taylor E
    Neuropsychopharmacology; 2011 Jul; 36(8):1575-86. PubMed ID: 21451498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared and disorder-specific task-positive and default mode network dysfunctions during sustained attention in paediatric Attention-Deficit/Hyperactivity Disorder and obsessive/compulsive disorder.
    Norman LJ; Carlisi CO; Christakou A; Cubillo A; Murphy CM; Chantiluke K; Simmons A; Giampietro V; Brammer M; Mataix-Cols D; Rubia K
    Neuroimage Clin; 2017; 15():181-193. PubMed ID: 28529874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.